
Marengo Asia Hospitals is a rapidly growing integrated network of multi-specialty hospitals focused on high-end tertiary and quaternary care. Under the leadership of Dr. Raajiv Singhal (Managing Director & Group CEO), the organization has established a significant presence in India with a capacity of over 1,800 beds and a team of 720+ skilled doctors.
The hospital chain is built on the 4A’s foundation: Accessibility, Affordability, Awareness, and Accountability. While many institutions focus on the first three, Marengo Asia distinguishes itself by making accountability—where every stakeholder is responsible for the clinical outcome—the cornerstone of its "Patient-First" philosophy.
Marengo Asia focuses on creating specialized hubs that set new standards in quality and measurable medical outcomes:
Cardiac Sciences: Renowned for performing complex interventional procedures and surgeries, including the region's first bloodless heart surgery.
Oncology & BMT: A comprehensive center for medical, surgical, and radiation oncology, featuring advanced Bone Marrow Transplant (BMT) units.
Liver Transplant & Biliary Sciences: Known for high success rates in adult and pediatric liver transplants.
Neurosciences: Features advanced Brain Stroke Centres with dedicated response units and state-of-the-art neuro-trauma care.
Orthopaedics & Robotic Surgery: Utilizes next-generation robotic systems (like Mako) for joint replacements, ensuring sub-millimeter precision.
A hallmark of Marengo Asia is its International Clinical Corridor, a unique global collaboration model designed to elevate healthcare standards in partner countries (such as Mongolia and the UK). This initiative operates on the 3T's principle:
Teach: Sharing medical knowledge through academic exchange.
Train: Equipping international doctors and nurses with advanced skills in India.
Treat: Providing complex medical treatments that may not be available in the partner's home country.